查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球T細胞療法市場：按適應症（血液惡性腫瘤,實體瘤,其他）,治療類型（CAR T細胞療法,基於TCR,基於TIL）,方式（研究,商業化）,地區2023-2033
市場調查報告書
商品編碼
1229629

全球T細胞療法市場：按適應症（血液惡性腫瘤,實體瘤,其他）,治療類型（CAR T細胞療法,基於TCR,基於TIL）,方式（研究,商業化）,地區2023-2033

Global T-cell Therapy Market by Indication (Hematologic Malignancies, Solid Tumours and Other Indications), by Therapy Type (CAR T-cell Therapy, TCR-based and TIL-based), by Modality (Research and Commercialized) and Region - 2023 to 2033
出版日期: | 出版商: Transparency Market Research | 英文 250 Pages | 商品交期: 2-10個工作天內

價格

TMR 的研究報告“全球 T 細胞治療市場”不僅包括過去的增長趨勢，還包括當前的增長趨勢和機會，以深入了解 2023 年至 2033 年預測期間的市場指標。我們正在調查。 本報告介紹了 2017 年至 2031 年全球 T 細胞治療市場的收入，基準年為 2023 年，預測年為 2033 年。 它還展示了 2023 年至 2033 年全球 T 細胞治療市場的複合年增長率 (CAGR %)。

這份報告是廣泛研究的結果。 在初步研究中，分析師對主要思想領袖,行業領袖和輿論製造者進行訪談，他們提供了大量的研究工作。 在我們的二次研究中，我們通過參考主要公司的產品文獻,年度報告,新聞稿和相關文件確定了 T 細胞療法市場。

該報告深入探討了全球 T 細胞療法市場的競爭格局。 已經確定了在全球 T 細胞治療市場運營的主要參與者，並且對每家公司進行了不同屬性的分析。 公司概況,財務狀況,近期市場發展和 SWOT 是本報告中描述的全球 T 細胞治療市場參與者的屬性。

內容

第 1 章執行摘要

  • 世界市場展望
  • 需求方面的趨勢
  • 供應方趨勢
  • 技術路線圖分析
  • 分析和建議

第 2 章市場概述

  • 市場覆蓋/分類
  • 市場定義/範圍/限制

第三章市場背景

  • 市場動態
    • 司機
    • 約束因素
    • 機會
    • 趨勢
  • 情景預測
    • 樂觀情景下的需求趨勢
    • 假設情景中的需求
    • 保守情景下的需求
  • 機會地圖分析
  • 投資可行性矩陣
  • 價值鏈分析
    • 利潤率分析
    • 服務提供商
  • PESTLE 分析和 Porters 分析
  • 監管狀況
    • 按主要地區
    • 按國家
  • 區域親子市場展望

第 4 章 2018-2022 年全球 T 細胞療法市場分析和 2023-2033 年預測

  • 2018-2022 年實際市場規模分析
  • 2023-2033 年當前和未來市場規模價值預測
    • 同比增長趨勢分析
    • 絕對數量機會分析

第 5 章 2018-2022 年全球 T 細胞療法市場分析和 2023-2033 年預測：按適應症分類

  • 簡介/主要評論
  • 2018-2022 年各適應症的市場規模價值分析
  • 2023-2033 年當前和未來市場規模價值分析和預測（按適應症分類）
    • 血液系統惡性腫瘤
      • 淋巴瘤
      • 白血病
      • 骨髓瘤
    • 實體癌
      • 黑色素瘤
      • 大腦和中樞神經系統
      • 肝癌
      • 其他實體瘤
    • 其他適應症
  • Yo-Y 增長趨勢分析（按適應症），2018-2022 年
  • 按適應症分類的絕對機會分析，2023 年至 2033 年

第 6 章 2018-2022 年全球 T 細胞療法市場分析，2023-2033 年預測：按治療類型

  • 簡介/主要評論
  • 2018-2022 年各治療類型的市場規模價值分析
  • 2023-2033 年按治療類型劃分的當前和未來市場規模價值分析和預測
    • CAR T 細胞療法
    • 基於 T 細胞受體 (TCR)
    • 基於腫瘤浸潤淋巴細胞 (TIL)
  • 2018-2022 年按治療類型分類的同比增長趨勢分析
  • 按治療類型分類的絕對數量機會分析 (2023-2033)

第 7 章 2018-2022 年全球 T 細胞療法市場分析和 2023-2033 年預測：按模式

  • 簡介/主要評論
  • 2018-2022 年各模式的市場規模績效價值分析
  • 2023-2033 年當前和未來市場規模價值分析和預測（按模式）
    • 調查
    • 商業化
  • 2018-2022 年各模式的同比增長趨勢分析
  • 2023-2033 年按形態分類的絕對數量機會分析

第 8 章 2018-2022 年全球 T 細胞療法市場分析，2023-2033 年預測：按地區

  • 介紹
  • 2018-2022 年各地區市場規模分析
  • 2023-2033 年當前市場規模價值分析和區域預測
    • 北美
    • 拉丁美洲
    • 歐洲
    • 亞太地區
    • 中東和非洲
  • 各地區的市場吸引力分析

第 9 章 2018-2022 年北美 T 細胞療法市場分析和 2023-2033 年預測：按國家/地區分類

  • 2018-2022 年按市場分類的市場規模表現趨勢分析
  • 按市場分類預測的市場規模，2023 年至 2033 年
    • 按國家
      • 美國
      • 加拿大
    • 按視圖
    • 按治療類型
    • 按方式
  • 市場吸引力分析
    • 按國家
    • 按視圖
    • 按治療類型
    • 按方式
  • 鑰匙帶走

第 10 章拉丁美洲 T 細胞療法市場分析 2018-2022 和預測 2023-2033：按國家/地區

  • 2018-2022 年按市場分類的市場規模表現趨勢分析
  • 按市場分類預測的市場規模，2023 年至 2033 年
    • 按國家
      • 巴西
      • 墨西哥
      • 其他拉丁美洲地區
    • 按視圖
    • 按治療類型
    • 按方式
  • 市場吸引力分析
    • 按國家
    • 按視圖
    • 按治療類型
    • 按方式
  • 鑰匙帶走

第 11 章歐洲 T 細胞療法市場分析 2018-2022 和預測 2023-2033：按國家/地區

  • 2018-2022 年按市場分類的市場規模表現趨勢分析
  • 按市場分類預測的市場規模，2023 年至 2033 年
    • 按國家
      • 德國
      • 意大利
      • 法國
      • 英國
      • 西班牙
      • 俄羅斯
      • 其他歐洲
    • 按視圖
    • 按治療類型
    • 按方式
  • 市場吸引力分析
    • 按國家
    • 按視圖
    • 按治療類型
    • 按方式
  • 鑰匙帶走

第 12 章亞太地區 T 細胞療法市場分析 2018-2022 和預測 2023-2033：按國家/地區

  • 2018-2022 年按市場分類的市場規模表現趨勢分析
  • 按市場分類預測的市場規模，2023 年至 2033 年
    • 按國家
      • 中國
      • 日本
      • 印度
      • 韓國
      • 澳大利亞
      • 亞太地區的其他國家
    • 按視圖
    • 按治療類型
    • 按方式
  • 市場吸引力分析
    • 按國家
    • 按視圖
    • 按治療類型
    • 按方式
  • 鑰匙帶走

第 13 章中東和非洲 T 細胞療法市場分析 2018-2022 和預測 2023-2033：按國家/地區

  • 2018-2022 年按市場分類的市場規模表現趨勢分析
  • 按市場分類預測的市場規模，2023 年至 2033 年
    • 按國家
      • 南非
      • 沙特阿拉伯
      • 阿聯酋
      • 以色列
      • 其餘中東和非洲地區
    • 按視圖
    • 按治療類型
    • 按方式
  • 市場吸引力分析
    • 按國家
    • 按視圖
    • 按治療類型
    • 按方式
  • 鑰匙帶走

第14章主要國家T細胞治療市場分析

  • 美國
    • 價格分析
    • 2022 年市場份額分析
      • 按視圖
      • 按治療類型
      • 按方式
  • 加拿大
    • 定價分析
    • 2022 年市場份額分析
      • 按視圖
      • 按治療類型
      • 按方式
  • 巴西
    • 定價分析
    • 2022 年市場份額分析
      • 按視圖
      • 按治療類型
      • 按方式
  • 墨西哥
    • 定價分析
    • 2022 年市場份額分析
      • 按視圖
      • 按治療類型
      • 按方式
  • 德國
    • 定價分析
    • 2022 年市場份額分析
      • 按視圖
      • 按治療類型
      • 按方式
  • 意大利
    • 定價分析
    • 2022 年市場份額分析
      • 按視圖
      • 按治療類型
      • 按方式
  • 法國
    • 價格分析
    • 2022 年市場份額分析
      • 按視圖
      • 按治療類型
      • 按方式
  • 英國
    • 價格分析
    • 2022 年市場份額分析
      • 按視圖
      • 按治療類型
      • 按方式
  • 西班牙
    • 價格分析
    • 2022 年市場份額分析
      • 按視圖
      • 按治療類型
      • 按方式
  • 俄羅斯
    • 定價分析
    • 2022 年市場份額分析
      • 按視圖
      • 按治療類型
      • 按方式
  • 中國
    • 定價分析
    • 2022 年市場份額分析
      • 按視圖
      • 按治療類型
      • 按方式
  • 日本
    • 定價分析
    • 2022 年市場份額分析
      • 按視圖
      • 按治療類型
      • 按方式
  • 印度
    • 定價分析
    • 2022 年市場份額分析
      • 按視圖
      • 按治療類型
      • 按方式
  • 韓國
    • 定價分析
    • 2022 年市場份額分析
      • 按視圖
      • 按治療類型
      • 按方式
  • 澳大利亞
    • 定價分析
    • 2022 年市場份額分析
      • 按視圖
      • 按治療類型
      • 按方式
  • 南非
    • 定價分析
    • 2022 年市場份額分析
      • 按視圖
      • 按治療類型
      • 按方式
  • 沙特阿拉伯
    • 定價分析
    • 2022 年市場份額分析
      • 按視圖
      • 按治療類型
      • 按方式
  • 阿聯酋
    • 定價分析
    • 2022 年市場份額分析
      • 按視圖
      • 按治療類型
      • 按方式
  • 以色列
    • 定價分析
    • 2022 年市場份額分析
      • 按視圖
      • 按治療類型
      • 按方式

第15章市場結構分析

  • 比賽儀表板
  • 競爭基準
  • 頂級公司的市場份額分析
    • 按地區
    • 按視圖
    • 按治療類型
    • 按方式

第 16 章競爭分析

  • 探索競爭的深度
    • Novartis AG
    • Merck KGaA
    • Gilead Sciences Inc.
    • TCR2 Therapeutics Inc
    • Bluebird Bio Inc
    • Sorrento Therapeutics
    • Fate Therapeutics
    • Pfizer Inc
    • Amgen
    • Celgene Corporation

第 17 章使用假設和縮寫

第 18 章研究方法論

Product Code: TMRGL75857

The report provides revenue of the global T-cell therapy market for the period 2017-2031, considering 2023 as the base year and 2033 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global T-cell therapy market from 2023 to 2033.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the T-cell therapy market.

The report delves into the competitive landscape of the global T-cell therapy market. Key players operating in the global T-cell therapy market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global T-cell therapy market profiled in this report.

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand-side Trends
  • 1.3. Supply-side Trends
  • 1.4. Technology Roadmap Analysis
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market Background

  • 3.1. Market Dynamics
    • 3.1.1. Drivers
    • 3.1.2. Restraints
    • 3.1.3. Opportunity
    • 3.1.4. Trends
  • 3.2. Scenario Forecast
    • 3.2.1. Demand in Optimistic Scenario
    • 3.2.2. Demand in Likely Scenario
    • 3.2.3. Demand in Conservative Scenario
  • 3.3. Opportunity Map Analysis
  • 3.4. Investment Feasibility Matrix
  • 3.5. Value Chain Analysis
    • 3.5.1. Profit Margin Analysis
    • 3.5.2. Service Providers
  • 3.6. PESTLE and Porter's Analysis
  • 3.7. Regulatory Landscape
    • 3.7.1. By Key Regions
    • 3.7.2. By Key Countries
  • 3.8. Regional Parent Market Outlook

4. Global T-cell Therapy Market Analysis 2018-2022 and Forecast, 2023-2033

  • 4.1. Historical Market Size Value (US$ Bn) Analysis, 2018-2022
  • 4.2. Current and Future Market Size Value (US$ Bn) Projections, 2023-2033
    • 4.2.1. Y-o-Y Growth Trend Analysis
    • 4.2.2. Absolute $ Opportunity Analysis

5. Global T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Indication

  • 5.1. Introduction / Key Findings
  • 5.2. Historical Market Size Value (US$ Bn) Analysis By Indication , 2018-2022
  • 5.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Indication , 2023-2033
    • 5.3.1. Hematologic Malignancies
      • 5.3.1.1. Lymphoma
      • 5.3.1.2. Leukemia
      • 5.3.1.3. Myeloma
    • 5.3.2. Solid Tumors
      • 5.3.2.1. Melanoma
      • 5.3.2.2. Brain & Central Nervous System
      • 5.3.2.3. Liver Cancer
      • 5.3.2.4. Other Solid Tumors
    • 5.3.3. Other Indications
  • 5.4. Y-o-Y Growth Trend Analysis By Indication , 2018-2022
  • 5.5. Absolute $ Opportunity Analysis By Indication , 2023-2033

6. Global T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Therapy Type

  • 6.1. Introduction / Key Findings
  • 6.2. Historical Market Size Value (US$ Bn) Analysis By Therapy Type, 2018-2022
  • 6.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Therapy Type, 2023-2033
    • 6.3.1. CAR T-cell Therapy
    • 6.3.2. T Cell Receptor (TCR)-based
    • 6.3.3. Tumor Infiltrating Lymphocytes (TIL)-based
  • 6.4. Y-o-Y Growth Trend Analysis By Therapy Type, 2018-2022
  • 6.5. Absolute $ Opportunity Analysis By Therapy Type, 2023-2033

7. Global T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Modality

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size Value (US$ Bn) Analysis By Modality , 2018-2022
  • 7.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Modality , 2023-2033
    • 7.3.1. Research
    • 7.3.2. Commercialized
  • 7.4. Y-o-Y Growth Trend Analysis By Modality , 2018-2022
  • 7.5. Absolute $ Opportunity Analysis By Modality , 2023-2033

8. Global T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Region

  • 8.1. Introduction
  • 8.2. Historical Market Size Value (US$ Bn) Analysis By Region, 2018-2022
  • 8.3. Current Market Size Value (US$ Bn) Analysis and Forecast By Region, 2023-2033
    • 8.3.1. North America
    • 8.3.2. Latin America
    • 8.3.3. Europe
    • 8.3.4. Asia Pacific
    • 8.3.5. MEA
  • 8.4. Market Attractiveness Analysis By Region

9. North America T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Country

  • 9.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2018-2022
  • 9.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2023-2033
    • 9.2.1. By Country
      • 9.2.1.1. U.S.
      • 9.2.1.2. Canada
    • 9.2.2. By Indication
    • 9.2.3. By Therapy Type
    • 9.2.4. By Modality
  • 9.3. Market Attractiveness Analysis
    • 9.3.1. By Country
    • 9.3.2. By Indication
    • 9.3.3. By Therapy Type
    • 9.3.4. By Modality
  • 9.4. Key Takeaways

10. Latin America T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Country

  • 10.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2018-2022
  • 10.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2023-2033
    • 10.2.1. By Country
      • 10.2.1.1. Brazil
      • 10.2.1.2. Mexico
      • 10.2.1.3. Rest of Latin America
    • 10.2.2. By Indication
    • 10.2.3. By Therapy Type
    • 10.2.4. By Modality
  • 10.3. Market Attractiveness Analysis
    • 10.3.1. By Country
    • 10.3.2. By Indication
    • 10.3.3. By Therapy Type
    • 10.3.4. By Modality
  • 10.4. Key Takeaways

11. Europe T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Country

  • 11.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2018-2022
  • 11.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2023-2033
    • 11.2.1. By Country
      • 11.2.1.1. Germany
      • 11.2.1.2. Italy
      • 11.2.1.3. France
      • 11.2.1.4. U.K.
      • 11.2.1.5. Spain
      • 11.2.1.6. Russia
      • 11.2.1.7. Rest of Europe
    • 11.2.2. By Indication
    • 11.2.3. By Therapy Type
    • 11.2.4. By Modality
  • 11.3. Market Attractiveness Analysis
    • 11.3.1. By Country
    • 11.3.2. By Indication
    • 11.3.3. By Therapy Type
    • 11.3.4. By Modality
  • 11.4. Key Takeaways

12. Asia Pacific T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Country

  • 12.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2018-2022
  • 12.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2023-2033
    • 12.2.1. By Country
      • 12.2.1.1. China
      • 12.2.1.2. Japan
      • 12.2.1.3. India
      • 12.2.1.4. South Korea
      • 12.2.1.5. Australia
      • 12.2.1.6. Rest of APAC
    • 12.2.2. By Indication
    • 12.2.3. By Therapy Type
    • 12.2.4. By Modality
  • 12.3. Market Attractiveness Analysis
    • 12.3.1. By Country
    • 12.3.2. By Indication
    • 12.3.3. By Therapy Type
    • 12.3.4. By Modality
  • 12.4. Key Takeaways

13. MEA T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Country

  • 13.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2018-2022
  • 13.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2023-2033
    • 13.2.1. By Country
      • 13.2.1.1. South Africa
      • 13.2.1.2. Saudi Arabia
      • 13.2.1.3. UAE
      • 13.2.1.4. Israel
      • 13.2.1.5. Rest of MEA
    • 13.2.2. By Indication
    • 13.2.3. By Therapy Type
    • 13.2.4. By Modality
  • 13.3. Market Attractiveness Analysis
    • 13.3.1. By Country
    • 13.3.2. By Indication
    • 13.3.3. By Therapy Type
    • 13.3.4. By Modality
  • 13.4. Key Takeaways

14. Key Countries T-cell Therapy Market Analysis

  • 14.1. U.S.
    • 14.1.1. Pricing Analysis
    • 14.1.2. Market Share Analysis, 2022
      • 14.1.2.1. By Indication
      • 14.1.2.2. By Therapy Type
      • 14.1.2.3. By Modality
  • 14.2. Canada
    • 14.2.1. Pricing Analysis
    • 14.2.2. Market Share Analysis, 2022
      • 14.2.2.1. By Indication
      • 14.2.2.2. By Therapy Type
      • 14.2.2.3. By Modality
  • 14.3. Brazil
    • 14.3.1. Pricing Analysis
    • 14.3.2. Market Share Analysis, 2022
      • 14.3.2.1. By Indication
      • 14.3.2.2. By Therapy Type
      • 14.3.2.3. By Modality
  • 14.4. Mexico
    • 14.4.1. Pricing Analysis
    • 14.4.2. Market Share Analysis, 2022
      • 14.4.2.1. By Indication
      • 14.4.2.2. By Therapy Type
      • 14.4.2.3. By Modality
  • 14.5. Germany
    • 14.5.1. Pricing Analysis
    • 14.5.2. Market Share Analysis, 2022
      • 14.5.2.1. By Indication
      • 14.5.2.2. By Therapy Type
      • 14.5.2.3. By Modality
  • 14.6. Italy
    • 14.6.1. Pricing Analysis
    • 14.6.2. Market Share Analysis, 2022
      • 14.6.2.1. By Indication
      • 14.6.2.2. By Therapy Type
      • 14.6.2.3. By Modality
  • 14.7. France
    • 14.7.1. Pricing Analysis
    • 14.7.2. Market Share Analysis, 2022
      • 14.7.2.1. By Indication
      • 14.7.2.2. By Therapy Type
      • 14.7.2.3. By Modality
  • 14.8. U.K.
    • 14.8.1. Pricing Analysis
    • 14.8.2. Market Share Analysis, 2022
      • 14.8.2.1. By Indication
      • 14.8.2.2. By Therapy Type
      • 14.8.2.3. By Modality
  • 14.9. Spain
    • 14.9.1. Pricing Analysis
    • 14.9.2. Market Share Analysis, 2022
      • 14.9.2.1. By Indication
      • 14.9.2.2. By Therapy Type
      • 14.9.2.3. By Modality
  • 14.10. Russia
    • 14.10.1. Pricing Analysis
    • 14.10.2. Market Share Analysis, 2022
      • 14.10.2.1. By Indication
      • 14.10.2.2. By Therapy Type
      • 14.10.2.3. By Modality
  • 14.11. China
    • 14.11.1. Pricing Analysis
    • 14.11.2. Market Share Analysis, 2022
      • 14.11.2.1. By Indication
      • 14.11.2.2. By Therapy Type
      • 14.11.2.3. By Modality
  • 14.12. Japan
    • 14.12.1. Pricing Analysis
    • 14.12.2. Market Share Analysis, 2022
      • 14.12.2.1. By Indication
      • 14.12.2.2. By Therapy Type
      • 14.12.2.3. By Modality
  • 14.13. India
    • 14.13.1. Pricing Analysis
    • 14.13.2. Market Share Analysis, 2022
      • 14.13.2.1. By Indication
      • 14.13.2.2. By Therapy Type
      • 14.13.2.3. By Modality
  • 14.14. South Korea
    • 14.14.1. Pricing Analysis
    • 14.14.2. Market Share Analysis, 2022
      • 14.14.2.1. By Indication
      • 14.14.2.2. By Therapy Type
      • 14.14.2.3. By Modality
  • 14.15. Australia
    • 14.15.1. Pricing Analysis
    • 14.15.2. Market Share Analysis, 2022
      • 14.15.2.1. By Indication
      • 14.15.2.2. By Therapy Type
      • 14.15.2.3. By Modality
  • 14.16. South Africa
    • 14.16.1. Pricing Analysis
    • 14.16.2. Market Share Analysis, 2022
      • 14.16.2.1. By Indication
      • 14.16.2.2. By Therapy Type
      • 14.16.2.3. By Modality
  • 14.17. Saudi Arabia
    • 14.17.1. Pricing Analysis
    • 14.17.2. Market Share Analysis, 2022
      • 14.17.2.1. By Indication
      • 14.17.2.2. By Therapy Type
      • 14.17.2.3. By Modality
  • 14.18. UAE
    • 14.18.1. Pricing Analysis
    • 14.18.2. Market Share Analysis, 2022
      • 14.18.2.1. By Indication
      • 14.18.2.2. By Therapy Type
      • 14.18.2.3. By Modality
  • 14.19. Israel
    • 14.19.1. Pricing Analysis
    • 14.19.2. Market Share Analysis, 2022
      • 14.19.2.1. By Indication
      • 14.19.2.2. By Therapy Type
      • 14.19.2.3. By Modality

15. Market Structure Analysis

  • 15.1. Competition Dashboard
  • 15.2. Competition Benchmarking
  • 15.3. Market Share Analysis of Top Players
    • 15.3.1. By Regional
    • 15.3.2. By Indication
    • 15.3.3. By Therapy Type
    • 15.3.4. By Modality

16. Competition Analysis

  • 16.1. Competition Deep Dive
    • 16.1.1. Novartis AG
      • 16.1.1.1. Overview
      • 16.1.1.2. Product Portfolio
      • 16.1.1.3. Profitability by Market Segments
      • 16.1.1.4. Sales Footprint
      • 16.1.1.5. Strategy Overview
        • 16.1.1.5.1. Marketing Strategy
        • 16.1.1.5.2. Product Strategy
        • 16.1.1.5.3. Channel Strategy
    • 16.1.2. Merck KGaA
      • 16.1.2.1. Overview
      • 16.1.2.2. Product Portfolio
      • 16.1.2.3. Profitability by Market Segments
      • 16.1.2.4. Sales Footprint
      • 16.1.2.5. Strategy Overview
        • 16.1.2.5.1. Marketing Strategy
        • 16.1.2.5.2. Product Strategy
        • 16.1.2.5.3. Channel Strategy
    • 16.1.3. Gilead Sciences Inc.
      • 16.1.3.1. Overview
      • 16.1.3.2. Product Portfolio
      • 16.1.3.3. Profitability by Market Segments
      • 16.1.3.4. Sales Footprint
      • 16.1.3.5. Strategy Overview
        • 16.1.3.5.1. Marketing Strategy
        • 16.1.3.5.2. Product Strategy
        • 16.1.3.5.3. Channel Strategy
    • 16.1.4. TCR2 Therapeutics Inc
      • 16.1.4.1. Overview
      • 16.1.4.2. Product Portfolio
      • 16.1.4.3. Profitability by Market Segments
      • 16.1.4.4. Sales Footprint
      • 16.1.4.5. Strategy Overview
        • 16.1.4.5.1. Marketing Strategy
        • 16.1.4.5.2. Product Strategy
        • 16.1.4.5.3. Channel Strategy
    • 16.1.5. Bluebird Bio Inc
      • 16.1.5.1. Overview
      • 16.1.5.2. Product Portfolio
      • 16.1.5.3. Profitability by Market Segments
      • 16.1.5.4. Sales Footprint
      • 16.1.5.5. Strategy Overview
        • 16.1.5.5.1. Marketing Strategy
        • 16.1.5.5.2. Product Strategy
        • 16.1.5.5.3. Channel Strategy
    • 16.1.6. Sorrento Therapeutics
      • 16.1.6.1. Overview
      • 16.1.6.2. Product Portfolio
      • 16.1.6.3. Profitability by Market Segments
      • 16.1.6.4. Sales Footprint
      • 16.1.6.5. Strategy Overview
        • 16.1.6.5.1. Marketing Strategy
        • 16.1.6.5.2. Product Strategy
        • 16.1.6.5.3. Channel Strategy
    • 16.1.7. Fate Therapeutics
      • 16.1.7.1. Overview
      • 16.1.7.2. Product Portfolio
      • 16.1.7.3. Profitability by Market Segments
      • 16.1.7.4. Sales Footprint
      • 16.1.7.5. Strategy Overview
        • 16.1.7.5.1. Marketing Strategy
        • 16.1.7.5.2. Product Strategy
        • 16.1.7.5.3. Channel Strategy
    • 16.1.8. Pfizer Inc
      • 16.1.8.1. Overview
      • 16.1.8.2. Product Portfolio
      • 16.1.8.3. Profitability by Market Segments
      • 16.1.8.4. Sales Footprint
      • 16.1.8.5. Strategy Overview
        • 16.1.8.5.1. Marketing Strategy
        • 16.1.8.5.2. Product Strategy
        • 16.1.8.5.3. Channel Strategy
    • 16.1.9. Amgen
      • 16.1.9.1. Overview
      • 16.1.9.2. Product Portfolio
      • 16.1.9.3. Profitability by Market Segments
      • 16.1.9.4. Sales Footprint
      • 16.1.9.5. Strategy Overview
        • 16.1.9.5.1. Marketing Strategy
        • 16.1.9.5.2. Product Strategy
        • 16.1.9.5.3. Channel Strategy
    • 16.1.10. Celgene Corporation
      • 16.1.10.1. Overview
      • 16.1.10.2. Product Portfolio
      • 16.1.10.3. Profitability by Market Segments
      • 16.1.10.4. Sales Footprint
      • 16.1.10.5. Strategy Overview
        • 16.1.10.5.1. Marketing Strategy
        • 16.1.10.5.2. Product Strategy
        • 16.1.10.5.3. Channel Strategy

17. Assumptions & Acronyms Used

18. Research Methodology

List of Tables

  • Table 1: Global T-cell Therapy Market Value (US$ Bn) Forecast by Region, 2018-2033
  • Table 2: Global T-cell Therapy Market Value (US$ Bn) Forecast by Indication , 2018-2033
  • Table 3: Global T-cell Therapy Market Value (US$ Bn) Forecast by Therapy Type, 2018-2033
  • Table 4: Global T-cell Therapy Market Value (US$ Bn) Forecast by Modality , 2018-2033
  • Table 5: North America T-cell Therapy Market Value (US$ Bn) Forecast by Country, 2018-2033
  • Table 6: North America T-cell Therapy Market Value (US$ Bn) Forecast by Indication , 2018-2033
  • Table 7: North America T-cell Therapy Market Value (US$ Bn) Forecast by Therapy Type, 2018-2033
  • Table 8: North America T-cell Therapy Market Value (US$ Bn) Forecast by Modality , 2018-2033
  • Table 9: Latin America T-cell Therapy Market Value (US$ Bn) Forecast by Country, 2018-2033
  • Table 10: Latin America T-cell Therapy Market Value (US$ Bn) Forecast by Indication , 2018-2033
  • Table 11: Latin America T-cell Therapy Market Value (US$ Bn) Forecast by Therapy Type, 2018-2033
  • Table 12: Latin America T-cell Therapy Market Value (US$ Bn) Forecast by Modality , 2018-2033
  • Table 13: Europe T-cell Therapy Market Value (US$ Bn) Forecast by Country, 2018-2033
  • Table 14: Europe T-cell Therapy Market Value (US$ Bn) Forecast by Indication , 2018-2033
  • Table 15: Europe T-cell Therapy Market Value (US$ Bn) Forecast by Therapy Type, 2018-2033
  • Table 16: Europe T-cell Therapy Market Value (US$ Bn) Forecast by Modality , 2018-2033
  • Table 17: Asia Pacific T-cell Therapy Market Value (US$ Bn) Forecast by Country, 2018-2033
  • Table 18: Asia Pacific T-cell Therapy Market Value (US$ Bn) Forecast by Indication , 2018-2033
  • Table 19: Asia Pacific T-cell Therapy Market Value (US$ Bn) Forecast by Therapy Type, 2018-2033
  • Table 20: Asia Pacific T-cell Therapy Market Value (US$ Bn) Forecast by Modality , 2018-2033
  • Table 21: MEA T-cell Therapy Market Value (US$ Bn) Forecast by Country, 2018-2033
  • Table 22: MEA T-cell Therapy Market Value (US$ Bn) Forecast by Indication , 2018-2033
  • Table 23: MEA T-cell Therapy Market Value (US$ Bn) Forecast by Therapy Type, 2018-2033
  • Table 24: MEA T-cell Therapy Market Value (US$ Bn) Forecast by Modality , 2018-2033

List of Figures

  • Figure 1: Global T-cell Therapy Market Value (US$ Bn) by Indication , 2023-2033
  • Figure 2: Global T-cell Therapy Market Value (US$ Bn) by Therapy Type, 2023-2033
  • Figure 3: Global T-cell Therapy Market Value (US$ Bn) by Modality , 2023-2033
  • Figure 4: Global T-cell Therapy Market Value (US$ Bn) by Region, 2023-2033
  • Figure 5: Global T-cell Therapy Market Value (US$ Bn) Analysis by Region, 2018-2033
  • Figure 6: Global T-cell Therapy Market Value Share (%) and BPS Analysis by Region, 2023-2033
  • Figure 7: Global T-cell Therapy Market Y-o-Y Growth (%) Projections by Region, 2023-2033
  • Figure 8: Global T-cell Therapy Market Value (US$ Bn) Analysis by Indication , 2018-2033
  • Figure 9: Global T-cell Therapy Market Value Share (%) and BPS Analysis by Indication , 2023-2033
  • Figure 10: Global T-cell Therapy Market Y-o-Y Growth (%) Projections by Indication , 2023-2033
  • Figure 11: Global T-cell Therapy Market Value (US$ Bn) Analysis by Therapy Type, 2018-2033
  • Figure 12: Global T-cell Therapy Market Value Share (%) and BPS Analysis by Therapy Type, 2023-2033
  • Figure 13: Global T-cell Therapy Market Y-o-Y Growth (%) Projections by Therapy Type, 2023-2033
  • Figure 14: Global T-cell Therapy Market Value (US$ Bn) Analysis by Modality , 2018-2033
  • Figure 15: Global T-cell Therapy Market Value Share (%) and BPS Analysis by Modality , 2023-2033
  • Figure 16: Global T-cell Therapy Market Y-o-Y Growth (%) Projections by Modality , 2023-2033
  • Figure 17: Global T-cell Therapy Market Attractiveness by Indication , 2023-2033
  • Figure 18: Global T-cell Therapy Market Attractiveness by Therapy Type, 2023-2033
  • Figure 19: Global T-cell Therapy Market Attractiveness by Modality , 2023-2033
  • Figure 20: Global T-cell Therapy Market Attractiveness by Region, 2023-2033
  • Figure 21: North America T-cell Therapy Market Value (US$ Bn) by Indication , 2023-2033
  • Figure 22: North America T-cell Therapy Market Value (US$ Bn) by Therapy Type, 2023-2033
  • Figure 23: North America T-cell Therapy Market Value (US$ Bn) by Modality , 2023-2033
  • Figure 24: North America T-cell Therapy Market Value (US$ Bn) by Country, 2023-2033
  • Figure 25: North America T-cell Therapy Market Value (US$ Bn) Analysis by Country, 2018-2033
  • Figure 26: North America T-cell Therapy Market Value Share (%) and BPS Analysis by Country, 2023-2033
  • Figure 27: North America T-cell Therapy Market Y-o-Y Growth (%) Projections by Country, 2023-2033
  • Figure 28: North America T-cell Therapy Market Value (US$ Bn) Analysis by Indication , 2018-2033
  • Figure 29: North America T-cell Therapy Market Value Share (%) and BPS Analysis by Indication , 2023-2033
  • Figure 30: North America T-cell Therapy Market Y-o-Y Growth (%) Projections by Indication , 2023-2033
  • Figure 31: North America T-cell Therapy Market Value (US$ Bn) Analysis by Therapy Type, 2018-2033
  • Figure 32: North America T-cell Therapy Market Value Share (%) and BPS Analysis by Therapy Type, 2023-2033
  • Figure 33: North America T-cell Therapy Market Y-o-Y Growth (%) Projections by Therapy Type, 2023-2033
  • Figure 34: North America T-cell Therapy Market Value (US$ Bn) Analysis by Modality , 2018-2033
  • Figure 35: North America T-cell Therapy Market Value Share (%) and BPS Analysis by Modality , 2023-2033
  • Figure 36: North America T-cell Therapy Market Y-o-Y Growth (%) Projections by Modality , 2023-2033
  • Figure 37: North America T-cell Therapy Market Attractiveness by Indication , 2023-2033
  • Figure 38: North America T-cell Therapy Market Attractiveness by Therapy Type, 2023-2033
  • Figure 39: North America T-cell Therapy Market Attractiveness by Modality , 2023-2033
  • Figure 40: North America T-cell Therapy Market Attractiveness by Country, 2023-2033
  • Figure 41: Latin America T-cell Therapy Market Value (US$ Bn) by Indication , 2023-2033
  • Figure 42: Latin America T-cell Therapy Market Value (US$ Bn) by Therapy Type, 2023-2033
  • Figure 43: Latin America T-cell Therapy Market Value (US$ Bn) by Modality , 2023-2033
  • Figure 44: Latin America T-cell Therapy Market Value (US$ Bn) by Country, 2023-2033
  • Figure 45: Latin America T-cell Therapy Market Value (US$ Bn) Analysis by Country, 2018-2033
  • Figure 46: Latin America T-cell Therapy Market Value Share (%) and BPS Analysis by Country, 2023-2033
  • Figure 47: Latin America T-cell Therapy Market Y-o-Y Growth (%) Projections by Country, 2023-2033
  • Figure 48: Latin America T-cell Therapy Market Value (US$ Bn) Analysis by Indication , 2018-2033
  • Figure 49: Latin America T-cell Therapy Market Value Share (%) and BPS Analysis by Indication , 2023-2033
  • Figure 50: Latin America T-cell Therapy Market Y-o-Y Growth (%) Projections by Indication , 2023-2033
  • Figure 51: Latin America T-cell Therapy Market Value (US$ Bn) Analysis by Therapy Type, 2018-2033
  • Figure 52: Latin America T-cell Therapy Market Value Share (%) and BPS Analysis by Therapy Type, 2023-2033
  • Figure 53: Latin America T-cell Therapy Market Y-o-Y Growth (%) Projections by Therapy Type, 2023-2033
  • Figure 54: Latin America T-cell Therapy Market Value (US$ Bn) Analysis by Modality , 2018-2033
  • Figure 55: Latin America T-cell Therapy Market Value Share (%) and BPS Analysis by Modality , 2023-2033
  • Figure 56: Latin America T-cell Therapy Market Y-o-Y Growth (%) Projections by Modality , 2023-2033
  • Figure 57: Latin America T-cell Therapy Market Attractiveness by Indication , 2023-2033
  • Figure 58: Latin America T-cell Therapy Market Attractiveness by Therapy Type, 2023-2033
  • Figure 59: Latin America T-cell Therapy Market Attractiveness by Modality , 2023-2033
  • Figure 60: Latin America T-cell Therapy Market Attractiveness by Country, 2023-2033
  • Figure 61: Europe T-cell Therapy Market Value (US$ Bn) by Indication , 2023-2033
  • Figure 62: Europe T-cell Therapy Market Value (US$ Bn) by Therapy Type, 2023-2033
  • Figure 63: Europe T-cell Therapy Market Value (US$ Bn) by Modality , 2023-2033
  • Figure 64: Europe T-cell Therapy Market Value (US$ Bn) by Country, 2023-2033
  • Figure 65: Europe T-cell Therapy Market Value (US$ Bn) Analysis by Country, 2018-2033
  • Figure 66: Europe T-cell Therapy Market Value Share (%) and BPS Analysis by Country, 2023-2033
  • Figure 67: Europe T-cell Therapy Market Y-o-Y Growth (%) Projections by Country, 2023-2033
  • Figure 68: Europe T-cell Therapy Market Value (US$ Bn) Analysis by Indication , 2018-2033
  • Figure 69: Europe T-cell Therapy Market Value Share (%) and BPS Analysis by Indication , 2023-2033
  • Figure 70: Europe T-cell Therapy Market Y-o-Y Growth (%) Projections by Indication , 2023-2033
  • Figure 71: Europe T-cell Therapy Market Value (US$ Bn) Analysis by Therapy Type, 2018-2033
  • Figure 72: Europe T-cell Therapy Market Value Share (%) and BPS Analysis by Therapy Type, 2023-2033
  • Figure 73: Europe T-cell Therapy Market Y-o-Y Growth (%) Projections by Therapy Type, 2023-2033
  • Figure 74: Europe T-cell Therapy Market Value (US$ Bn) Analysis by Modality , 2018-2033
  • Figure 75: Europe T-cell Therapy Market Value Share (%) and BPS Analysis by Modality , 2023-2033
  • Figure 76: Europe T-cell Therapy Market Y-o-Y Growth (%) Projections by Modality , 2023-2033
  • Figure 77: Europe T-cell Therapy Market Attractiveness by Indication , 2023-2033
  • Figure 78: Europe T-cell Therapy Market Attractiveness by Therapy Type, 2023-2033
  • Figure 79: Europe T-cell Therapy Market Attractiveness by Modality , 2023-2033
  • Figure 80: Europe T-cell Therapy Market Attractiveness by Country, 2023-2033
  • Figure 81: Asia Pacific T-cell Therapy Market Value (US$ Bn) by Indication , 2023-2033
  • Figure 82: Asia Pacific T-cell Therapy Market Value (US$ Bn) by Therapy Type, 2023-2033
  • Figure 83: Asia Pacific T-cell Therapy Market Value (US$ Bn) by Modality , 2023-2033
  • Figure 84: Asia Pacific T-cell Therapy Market Value (US$ Bn) by Country, 2023-2033
  • Figure 85: Asia Pacific T-cell Therapy Market Value (US$ Bn) Analysis by Country, 2018-2033
  • Figure 86: Asia Pacific T-cell Therapy Market Value Share (%) and BPS Analysis by Country, 2023-2033
  • Figure 87: Asia Pacific T-cell Therapy Market Y-o-Y Growth (%) Projections by Country, 2023-2033
  • Figure 88: Asia Pacific T-cell Therapy Market Value (US$ Bn) Analysis by Indication , 2018-2033
  • Figure 89: Asia Pacific T-cell Therapy Market Value Share (%) and BPS Analysis by Indication , 2023-2033
  • Figure 90: Asia Pacific T-cell Therapy Market Y-o-Y Growth (%) Projections by Indication , 2023-2033
  • Figure 91: Asia Pacific T-cell Therapy Market Value (US$ Bn) Analysis by Therapy Type, 2018-2033
  • Figure 92: Asia Pacific T-cell Therapy Market Value Share (%) and BPS Analysis by Therapy Type, 2023-2033
  • Figure 93: Asia Pacific T-cell Therapy Market Y-o-Y Growth (%) Projections by Therapy Type, 2023-2033
  • Figure 94: Asia Pacific T-cell Therapy Market Value (US$ Bn) Analysis by Modality , 2018-2033
  • Figure 95: Asia Pacific T-cell Therapy Market Value Share (%) and BPS Analysis by Modality , 2023-2033
  • Figure 96: Asia Pacific T-cell Therapy Market Y-o-Y Growth (%) Projections by Modality , 2023-2033
  • Figure 97: Asia Pacific T-cell Therapy Market Attractiveness by Indication , 2023-2033
  • Figure 98: Asia Pacific T-cell Therapy Market Attractiveness by Therapy Type, 2023-2033
  • Figure 99: Asia Pacific T-cell Therapy Market Attractiveness by Modality , 2023-2033
  • Figure 100: Asia Pacific T-cell Therapy Market Attractiveness by Country, 2023-2033
  • Figure 101: MEA T-cell Therapy Market Value (US$ Bn) by Indication , 2023-2033
  • Figure 102: MEA T-cell Therapy Market Value (US$ Bn) by Therapy Type, 2023-2033
  • Figure 103: MEA T-cell Therapy Market Value (US$ Bn) by Modality , 2023-2033
  • Figure 104: MEA T-cell Therapy Market Value (US$ Bn) by Country, 2023-2033
  • Figure 105: MEA T-cell Therapy Market Value (US$ Bn) Analysis by Country, 2018-2033
  • Figure 106: MEA T-cell Therapy Market Value Share (%) and BPS Analysis by Country, 2023-2033
  • Figure 107: MEA T-cell Therapy Market Y-o-Y Growth (%) Projections by Country, 2023-2033
  • Figure 108: MEA T-cell Therapy Market Value (US$ Bn) Analysis by Indication , 2018-2033
  • Figure 109: MEA T-cell Therapy Market Value Share (%) and BPS Analysis by Indication , 2023-2033
  • Figure 110: MEA T-cell Therapy Market Y-o-Y Growth (%) Projections by Indication , 2023-2033
  • Figure 111: MEA T-cell Therapy Market Value (US$ Bn) Analysis by Therapy Type, 2018-2033
  • Figure 112: MEA T-cell Therapy Market Value Share (%) and BPS Analysis by Therapy Type, 2023-2033
  • Figure 113: MEA T-cell Therapy Market Y-o-Y Growth (%) Projections by Therapy Type, 2023-2033
  • Figure 114: MEA T-cell Therapy Market Value (US$ Bn) Analysis by Modality , 2018-2033
  • Figure 115: MEA T-cell Therapy Market Value Share (%) and BPS Analysis by Modality , 2023-2033
  • Figure 116: MEA T-cell Therapy Market Y-o-Y Growth (%) Projections by Modality , 2023-2033
  • Figure 117: MEA T-cell Therapy Market Attractiveness by Indication , 2023-2033
  • Figure 118: MEA T-cell Therapy Market Attractiveness by Therapy Type, 2023-2033
  • Figure 119: MEA T-cell Therapy Market Attractiveness by Modality , 2023-2033
  • Figure 120: MEA T-cell Therapy Market Attractiveness by Country, 2023-2033